Philogen SpA ($DE:78Q) announced an update on their ongoing clinical study. Philogen S.p.A. is conducting a Phase 2 clinical study titled ‘A Phase ...

The global incidence of basal cell carcinoma is increasing due to prolonged exposure to ultraviolet (UV) radiation, genetic predispositions, and an aging population that is more susceptible to skin ...

A new study led by researchers at the Johns Hopkins Kimmel Cancer Center found that patients with advanced basal cell carcinoma (BCC) may benefit from receiving immunotherapy earlier in the course of ...

NDA for treatment of sBCC with Ameluz®-PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025First ...

Some blood pressure medications can make the skin extra prone to sunburn. A registry study from Lund University in Sweden ...

WOBURN, Mass., Jan. 08, 2025 (GLOBE NEWSWIRE) -- Biofrontera Inc. (BFRI) (“Biofrontera” or the “Company”), a biopharmaceutical company specializing in the development and commercialization of ...

A new study reveals that small cell lung cancer (SCLC) likely begins in basal stem-like cells rather than in neuroendocrine cells, marking a major shift in the understanding of this aggressive disease ...

Basal cell carcinoma often appears as a shiny bump or red patch on sun-exposed skin. Aside from appearance, some skin cancers may feel tender, itchy, or painful, or may bleed. Early detection of skin ...

Some blood pressure medications may increase sensitivity to sunlight and raise the risk of developing a common form of skin ...